Sudden cardiac death with autopsy findings of uncertain significance: Potential for erroneous interpretation

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 3, 2013, Pages 588-596

  Papadakis, Michael ^a,b   Raju, Hariharan ^a,b   Behr, Elijah R ^a   De Noronha, Sofia V ^c   Spath, Nicholas ^b   Kouloubinis, Alexandros ^b   Sheppard, Mary N ^c   Sharma, Sanjay ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac arrhythmia; Cardiomyopathies; Death; Ion channel; Pathology; Sudden cardiac

Indexed keywords

ADOLESCENT; ADULT; ARRHYTHMOGENESIS; ARTICLE; AUTOPSY; BRUGADA SYNDROME; CARDIOMYOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ERROR; DISEASE SEVERITY; FAMILY; FEMALE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; LONG QT SYNDROME 1; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATHOGENESIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SUDDEN CARDIAC DEATH; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; DEATH, SUDDEN CARDIAC; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; IMMUNOHISTOCHEMISTRY; LONG QT SYNDROME; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; PATHOLOGY; RETROSPECTIVE STUDY; UNCERTAINTY;

ION CHANNEL;

CARDIAC ARRHYTHMIA; CARDIOMYOPATHIES; DEATH, SUDDEN CARDIAC; ION CHANNEL; PATHOLOGY;

ADOLESCENT; ADULT; AUTOPSY; BIOPSY, NEEDLE; CARDIOMYOPATHIES; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; LONG QT SYNDROME; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; UNCERTAINTY; YOUNG ADULT;

EID: 84884472746     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000111     Document Type: Article

References (35)

1. Behr ER, Casey A, Sheppard M, Wright M, Bowker TJ, Davies MJ, McKenna WJ, Wood DA. Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death. Heart. 2007;93:601-605.
2. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation. 2005;112:207-213.
3. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT, Rowland E, Jeffery S, McKenna WJ. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J. 2008;29:1670-1680.
4. Basso C, Burke M, Fornes P, Gallagher PJ, de Gouveia RH, Sheppard M, Thiene G, van der Wal A; Association for European Cardiovascular Pathology. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452:11-18.
5. de Noronha SV, Sharma S, Papadakis M, Desai S, Whyte G, Sheppard MN. Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study. Heart. 2009;95:1409-1414.
6. Tansey DK, Aly Z, Sheppard MN. Fat in the right ventricle of the normal heart. Histopathology. 2005;46:98-104.
7. Govindan M, Batchvarov VN, Raju H, Shanmugam N, Bizrah M, Bastiaenen R, Kiotsekoglou A, Camm J, Behr ER. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome. Heart. 2010;96:1904-1908.
8. Garratt CJ, Elliott P, Behr E, Blair E, Connelly D, Cowan C, Davidson N, Grace A, Griffith M, Jolly A, Lambiase P MW. Clinical indications for genetic testing in familial sudden cardiac death syndromes: an HRUK position statement. Heart. 2008;94:502-507.
9. Zhang T, Moss A, Cong P, Pan M, Chang B, Zheng L, Fang Q, Zareba W, Robinson J, Lin C, Li Z, Wei J, Zeng Q, Qi M; Long QT International Registry Investigators; HVP-China Investigators. LQTS gene LOVD database. Hum Mutat. 2010;31:E1801-E1810.
10. Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, Mannens MM, Wilde AA, Ackerman MJ. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol. 2009;54:2065-2074.
11. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30:3894-3900.
12. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31:3812-3814.
13. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88:782-784.
14. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111:659-670.
15. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69-74.
16. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270-276.
17. Sheppard MN. The coronary arteries -atherosclerosis and ischaemic heart disease. In Sheppard MN, ed. Practical Cardiovascular Pathology. 2nd ed. London, England: Hodder Arnold; 2011:39-41.
18. Sheppard MN. Myocarditis. In Sheppard MN, ed. Practical Cardiovascular Pathology. 2nd ed. London, England: Hodder Arnold; 2011:204-206.
19. Yutaka I, Yusuke T, Kaoru S, Yasuhiko T, Toshio Y, Toshio F, Masaru Y, Yoshifusa A, Akira S. Coronary artery spasm is a major cause of sudden cardiac arrest in survivors without underlying heart disease. Coronary Artery Disease 1993;4:177-186.
20. Bharati S, Lev M. Cardiac conduction system involvement in sudden death of obese young people. Am Heart J. 1995;129:273-281.
21. Sze E, Moss AJ, Goldenberg I, McNitt S, Jons C, Zareba W, Qi M, Robinson JL; International Long QT Syndrome Investigative Group. Long QT syndrome in patients over 40 years of age: increased risk for LQTSrelated cardiac events in patients with coronary disease. Ann Noninvasive Electrocardiol. 2008;13:327-331.
22. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol. 2006;29:1130-1159.
23. Ohkubo K, Watanabe I, Okumura Y, Takagi Y, Ashino S, Kofune M, Sugimura H, Nakai T, Kasamaki Y, Hirayama A, Morimoto S. Right ventricular histological substrate and conduction delay in patients with Brugada syndrome. Int Heart J. 2010;51:17-23.
24. Watanabe H, Yang T, Stroud DM, Lowe JS, Harris L, Atack TC, Wang DW, Hipkens SB, Leake B, Hall L, Kupershmidt S, Chopra N, Magnuson MA, Tanabe N, Knollmann BC, George AL Jr, Roden DM. Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation. 2011;124:1001-1011.
25. Papavassiliu T, Veltmann C, Doesch C, Haghi D, Germans T, Schoenberg SO, van Rossum AC, Schimpf R, Brade J, Wolpert C, Borggrefe M. Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome. Heart Rhythm. 2010;7:1790-1796.
26. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, Likittanasombat K, Bhuripanyo K, Ngarmukos T. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270-1279.
27. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10:189-194.
28. McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E, Mestroni L; Familial Cardiomyopathy Registry Research Group. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation. 2004;110:2163-2167.
29. Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ, Horton SC, Rodeheffer RJ, Anderson JL. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA. 2005;293:447-454.
30. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454-1459.
31. Tomaselli GF, Marbán E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res. 1999;42:270-283.
32. de Jong S, van Veen TA, van Rijen HV, de Bakker JM. Fibrosis and cardiac arrhythmias. J Cardiovasc Pharmacol. 2011;57:630-638.
33. Royer A, van Veen TA, Le Bouter S, Marionneau C, Griol-Charhbili V, Léoni AL, Steenman M, van Rijen HV, Demolombe S, Goddard CA, Richer C, Escoubet B, Jarry-Guichard T, Colledge WH, Gros D, de Bakker JM, Grace AA, Escande D, Charpentier F. Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation. 2005;111:1738-1746.
34. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD, Guerchicoff A, Matsuo K, Burashnikov E, Dumaine R, Towbin JA, Nesterenko V, Brugada P, Antzelevitch C, Brugada R. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation. 2004;110:3023-3027.
35. Human Tissue Act 2004. Human Tissue Authority. http://www.legislation. gov.uk/ukpga/2004/30/contents. Accessed September 3, 2012.